Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01006902 · ClinicalTrials.gov registry record
Outcomes of Oncology Therapy in the Elderly: Trajectory of Functional Decline and Correlates of Change
A clinical trial, sponsored by University of Vermont.
- Terminated
- Registry status
- 3
- Enrollment target
NCT01006902: Clinical Trial study, sponsored by University of Vermont.
NCT01006902 is a clinical trial that was terminated before completion, run by University of Vermont. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01006902 was terminated before completion, sponsored by University of Vermont.
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
The proposed project will document the degree of function decline, assess the relationship between function and cancer- related symptoms and evaluate relationships between function and quality of life. Participants are evaluated before therapy, after therapy and again 3 months post therapy to evaluate functional change. Knowledge gained will help us plan interventions around the time of cancer therapy to help older adults preserve or improve function.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2009-11 |
| Est. Completion | 2011-05 |
Why NCT01006902 stopped before completion
NCT01006902 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01006902 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01006902 about?
NCT01006902 is a clinical study titled "Outcomes of Oncology Therapy in the Elderly: Trajectory of Functional Decline and Correlates of Change". The proposed project will document the degree of function decline, assess the relationship between function and cancer- related symptoms and evaluate relationships between function and quality of life. Participants are evaluated before therapy, after therapy and again 3 months post therapy to evalua...
What is the current status of trial NCT01006902?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2009-11. Estimated completion is 2011-05.
Who is sponsoring clinical trial NCT01006902?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia